Indonesian Political, Business & Finance News

The Foundation for Phytochemical Development and a Sustainable Health Industry

| | Source: Republika Translated from Indonesian | Economy
The Foundation for Phytochemical Development and a Sustainable Health Industry
Image: Republika

The development of phytochemistry and a sustainable health industry is one of the important strategies for harnessing Indonesia’s wealth of biodiversity. As a megabiodiverse country, Indonesia has thousands of plant species with the potential to serve as sources of bioactive compounds for the development of medicines, health supplements, cosmetics and pharmaceutical products. This potential makes medicinal plants the primary foundation of phytochemistry, the science that studies the natural chemical compounds contained in plants along with their biological activities. According to Harborne (1998), plants produce a variety of secondary metabolites that serve important functions in natural defence whilst also holding potential as raw materials for the modern health industry.

Various secondary metabolite compounds contained in plants, such as alkaloids, flavonoids, tannins, saponins, terpenoids, steroids, glycosides and phenolic compounds, are known to possess diverse biological activities. These compounds act as antioxidants, antibacterial, antiviral, antifungal, anticancer, antidiabetic, anti-inflammatory and even immunomodulatory agents. Therefore, the exploration and characterisation of phytochemical content in various Indonesian plants is a strategic step towards producing health products that are safe, effective, of high quality and economically valuable. Phytochemical research also provides the scientific basis for proving the efficacy of medicinal plants that have long been used traditionally.

The use of medicinal plants in Indonesia has long taken place through local knowledge passed down through generations. Various plants such as turmeric (Curcuma longa), Javanese turmeric (Curcuma xanthorrhiza), ginger (Zingiber officinale), sambiloto (Andrographis paniculata), meniran (Phyllanthus niruri), pegagan (Centella asiatica), betel leaf (Piper betle) and kumis kucing (Orthosiphon aristatus) have been used by communities as traditional remedies. A number of scientific studies have since proven that these plants contain bioactive compounds with pharmacological benefits. The World Health Organization (2013) has also stated that around 80 per cent of the world’s population still relies on traditional medicine as part of primary healthcare, meaning opportunities for nature-based industries continue to grow.

Advances in science and technology have driven the transformation of the jamu industry into a more modern health industry. Nature-based products are no longer produced solely on the basis of empirical experience, but now undergo extraction processes, identification of active compounds, quality standardisation, and safety and efficacy testing through preclinical and clinical trials. According to BPOM (2022), the development of natural medicines must meet quality, safety and efficacy requirements in order to compete in both national and international markets. Phytochemistry thus provides the scientific foundation supporting the emergence of phytopharmaceutical products of a quality equivalent to modern pharmaceuticals.

Beyond the scientific aspect, phytochemical development is also supported by the wealth of ethnobotanical knowledge among Indonesian communities. Each region has its own traditions of using medicinal plants, differing in the types of plants, processing techniques, dosages and herbal combinations used to treat various illnesses. This local knowledge is an extremely valuable source of information in the search for new bioactive compounds. Martin (1995) explained that ethnobotany serves as a bridge between traditional knowledge and scientific research, thereby accelerating the discovery of plants with potential for development into medicinal raw materials.

Despite its enormous potential, the development of phytochemistry and the plant-based health industry still faces various challenges. One of the main obstacles is the exploitation of natural resources that does not fully apply sustainability principles. Excessive harvesting of medicinal plants from their natural habitats, without accompanying cultivation, can lead to declining populations and even threaten the survival of certain species. In addition, deforestation, land conversion and climate change also affect the presence of many medicinal plants in the wild. Therefore, conservation and sustainable management of biological resources are prerequisites for maintaining the continuity of a biodiversity-based health industry (Bappenas, 2016).

Another challenge is the limited research on many plant species native to Indonesia. Most endemic plants have not been studied in depth regarding their phytochemical content or biological activity. Yet these species have the potential to yield new compounds that could be developed into innovative medicines. This situation underlines the importance of increased research investment, laboratory strengthening, and collaboration between universities, research institutes, government and industry to accelerate national phytochemical development.

From a national development perspective, phytochemical development based on medicinal plants also supports the independence of Indonesia’s pharmaceutical industry. Until now, the supply of pharmaceutical raw materials has relied heavily on imports, making the utilisation of local resources a strategic step towards strengthening the resilience of the health sector. The cultivation of medicinal plants, downstream processing of research outcomes, increased capacity of the phytopharmaceutical industry, and protection of traditional knowledge will create added economic value whilst opening export opportunities for nature-based products.

Phytochemistry is therefore the primary foundation for building a sustainable health industry. Indonesia’s wealth of medicinal plants, supported by high biodiversity, traditional knowledge and advances in scientific research, constitutes a strategic asset for producing health product innovations that are safe, of high quality and globally competitive. Through synergy between biodiversity conservation, strengthened research, industrial development and supportive government policy, Indonesia has a significant opportunity to become an international centre for phytochemical development and a sustainable health industry.

More from 15 July 2026 →

Cite this article
Source: jawawa.id (https://jawawa.id/newsitem/the-foundation-for-phytochemical-development-and-a-sustainable-health-industry-1784083907)
Originally published by Republika (https://retizen.republika.co.id/posts/771330/fondasi-pengembangan-fitokimia-dan-industri-kesehatan-berkelanjutan), translated from Indonesian
Print